Overview
Antithrombotic Therapy in patients with Acute Coronary Syndromes
Elderly patients with Heart Disease
Biomarkers in Acute Coronary Syndromes and Atrial Fibrillation
Thrombosis and Anticoagulation and novel antithrombotic agents
Metabolomics in Cardiovascular Medicine
Current Appointments & Affiliations
Professor of Medicine
·
2021 - Present
Medicine, Cardiology,
Medicine
Member in the Duke Clinical Research Institute
·
2009 - Present
Duke Clinical Research Institute,
Institutes and Centers
Recent Publications
Medicare coverage gap status, adherence to oral anticoagulation, and stroke rates in patients with atrial fibrillation.
Journal Article Am Heart J · January 2026 BACKGROUND: Prior to 2025, Medicare Part D included a coverage gap during which beneficiaries were responsible for substantially higher portions of medication costs. The impact of this on oral anticoagulant (OAC) prescription fills and subsequent stroke in ... Full text Link to item CiteCatheter ablation in patients with atrial fibrillation and cancer: a systematic review and updated meta-analysis.
Journal Article J Interv Card Electrophysiol · November 13, 2025 BACKGROUND: Atrial fibrillation (AF) is common in cancer patients, and catheter ablation (CA) is a treatment option. However, outcomes of CA in cancer patients remain unclear. OBJECTIVES: To evaluate the outcomes of CA for AF in patients with a current or ... Full text Link to item CiteFactor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism.
Journal Article Nat Rev Cardiol · November 2025 Therapeutic anticoagulation is essential to prevent and treat venous and arterial thromboembolism. The available agents target coagulation factors involved in thrombus formation but are associated with an increased risk of bleeding. Factor XI plays a minor ... Full text Link to item CiteRecent Grants
Protocol CS12_CEC
Clinical TrialPrincipal Investigator · Awarded by Ionis Pharmaceuticals Inc · 2025 - 2029A PROGRAM OF THREE STUDIES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Clinical TrialPrincipal Investigator · Awarded by Parexel International LLC · 2021 - 2029Priovant BREPO
Clinical TrialPrincipal Investigator · Awarded by Priovant Therapeutics, Inc · 2022 - 2027View All Grants
Education, Training & Certifications
Duke University, School of Medicine ·
2009
M.H.S.
Paulista Medical School, University of Sao Paulo (Brazil) ·
2006
Ph.D.
University of Santo Amaro (Brazil) ·
2001
M.D.